Publication | Closed Access

Patients mobilizing large numbers of CD34+ cells (‘super mobilizers’) have improved survival in autologous stem cell transplantation for lymphoid malignancies

‘ Super MobilizersCell TherapyTransplantationMarrow TransplantationStem Cell MobilizationStem Cell TransplantationImmunologyCd34+ CellsStem Cell ResearchCell TransplantationStem Cell TherapiesCell BiologyStem Cell TraffickingImmunotherapyMedicineCellular TherapiesLymphoid Malignancies